Dr. Huang is the Chief Medical Officer at Motif Bio, and the former Chief Medical Officer at ContraFect Corporation. Dr. Huang has also led drug development groups in anti-infectives at Pfizer and Boehringer-Ingelheim. Dr. Huang has 15 years of clinical, academic and research experience in medicine and in the subspeciality of infectious diseases. His research interests include bacteriology and virology, especially the epidemiology, pathogenesis, and treatment of multi-drug resistant organisms. He is well versed in the design, execution and close out of Phase I – III clinical trials for both antibacterials and antiviral agents. Dr. Huang completed his medical school at the University of Texas at Houston Medical School, and completed his internship and residency in internal medicine at the University of Texas at Southwestern and fellowship in infectious diseases at Baylor College of Medicine.